| sanofi-aventis US LLC Patent applications |
| Patent application number | Title | Published |
|---|
| 20120107277 | USE OF THE COMBINATION OF TERIFLUNOMIDE AND INTERFERON BETA FOR TREATING MULTIPLE SCLEROSIS - This invention is related to the use of the combination of teriflunomide and interferon beta thereof, for the preparation of a medicament for use in treating multiple sclerosis. | 05-03-2012 |
| 20120090957 | APPARATUS AND METHOD FOR LOADING AND UNLOADING CONTAINERS - An apparatus for loading and unloading a plurality of shipping containers into a carrier. The containers are arranged according to a predetermined pattern on a fixed staging unit of the apparatus. A first conveyor of the apparatus receives and transports the arranged containers from the fixed staging unit. The first conveyor is movable horizontally. A second conveyor of the apparatus receives the containers from the first conveyor and transports the containers into the carrier. The second conveyor is movable horizontally and vertically. A control unit of the apparatus controls transportation of the containers from the second conveyor into the carrier when the second conveyor is vertically moved to a predetermined position. | 04-19-2012 |
| 20110224214 | PROCESS FOR PREPARING POLYMORPH - Disclosed is a novel process for preparing crystalline Form II of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide. | 09-15-2011 |
| 20110015400 | PROCESS FOR THE PREPARATION OF TRYPTASE INHIBITORS - This invention is directed to processes for the preparation of a compound of the formula I or salt thereof, | 01-20-2011 |
| 20100174088 | PROCESS FOR THE PREPARATION OF BENZIMIDAZOL THIENYLAMINE COMPOUNDS AND DERIVATIVES THEREOF USEFUL AS SODIUM/PROTON EXCHANGER TYPE 3 INHIBITORS - The present invention is an improved process for the preparation of a sodium/proton exchange inhibitor of sub-type 3 (NHE-3) useful in the treatment of sleep apnea and other related respiratory disorders. The improved synthesis of the NHE-3 inhibitor, more specifically a benzimidazol thienylamine, utilizes novel reagents and chemical intermediates and thereby results in an improved yield and purity of the final product with less reaction or synthetic steps required | 07-08-2010 |
| 20090320572 | THE QUANTITATIVE DETERMINATION OF RISEDRONATE IN URINE BY SPE-LC-MS-MS - The present invention is directed to a SPE-LC-MS-MS method for quantitatively determining risedronate in a urine sample. | 12-31-2009 |
| 20080299211 | FEXOFENADINE SUSPENSION FORMULATION - The present invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I. | 12-04-2008 |
